12:43 PM
 | 
Apr 10, 2019
 |  BC Extra  |  Clinical News

Aetion, Brigham and Women's partnerships will inform FDA RWE standards

Editor's Note: This article was updated on Apr 10, 2019 at 2:13 PM PDT

FDA is expanding its real-world evidence partnership with Brigham and Women's Hospital and Aetion to use real-world evidence to predict clinical outcomes from trials. The results from this expansion should help the agency identify when and how RWE could provide robust estimates of safety and efficacy to support sNDAs.

On Wednesday, the partners announced that they would use Aetion's platform and healthcare claims data to predict safety and efficacy outcomes of seven ongoing...

Read the full 344 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >